Evidence map›Paper›PMID 34434497›Full record

ArticleOncotarget2021

Scent test using

Ayumu Asai, Masamitsu Konno, Miyuki Ozaki, Koichi Kawamoto, Ryota Chijimatsu, Nobuaki Kondo, Takaaki Hirotsu, Hideshi Ishii

Abstract read
In one paragraph

Article in Oncotarget, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. A non-invasive screening method usingBiochemistry and biophysics reports · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Biomedicines · 2022
    Review
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ayumu AsaiCenter of Medical Innovation and Translational Research (CoMIT), Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Masamitsu KonnoCenter of Medical Innovation and Translational Research (CoMIT), Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Miyuki OzakiCenter of Medical Innovation and Translational Research (CoMIT), Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Koichi KawamotoCenter of Medical Innovation and Translational Research (CoMIT), Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Ryota ChijimatsuCenter of Medical Innovation and Translational Research (CoMIT), Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Nobuaki KondoCenter of Medical Innovation and Translational Research (CoMIT), Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Takaaki HirotsuCenter of Medical Innovation and Translational Research (CoMIT), Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Hideshi IshiiCenter of Medical Innovation and Translational Research (CoMIT), Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although early detection and diagnosis are indispensable for improving the prognosis of patients with pancreatic cancer, both have yet to be achieved. Except for pancreatic cancer, other cancers have already been screened through scent tests using animals or microorganisms, including

Indexed as

biomarkerCaenorhabditis elegansdiagnosisearly-stage pancreatic cancerscent test

Identifiers

PMID34434497
PMCPMC8378769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.